Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis—a case control study

The prognosis of metastatic pancreatic ductal adenocarcinoma (PDAC) is grim, with a median overall survival of under 1 year. In our clinical practice, we observed a few cases of isolated lung metastases from PDAC with unusually long outcomes. We compared these cases in a case-control study of lung-o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Claire, Decoster, Marine, Gilabert, Aurélie, Autret, Olivier, Turrini, Sandrine, Oziel-Taieb, Flora, Poizat, Marc, Giovannini, Patrice, Viens, Juan, Iovanna, Jean-Luc, Raoul
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216749/
https://ncbi.nlm.nih.gov/pubmed/27286454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9861
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak